Table 2.
Demographic and Physiological Characteristics of Trial Participants upon Recruitment
| Patient Characteristics | |
|---|---|
| Age, yr, mean (range) | 71.9 (60–94) |
| Male sex, n (%) | 9 (43%) |
| Smoking status | |
| Never, n | 13 |
| Ex-smoker, n (pack-year history) | 6 (21.5) |
| Current, n (pack-year history) | 2 (21.5) |
| Comorbid conditions | |
| Hypertension | 6 |
| Medications | |
| Antihypertensive drugs | |
| ACEi | 1 |
| Diuretics | 1 |
| Ca2+ channel blocker + diuretic | 3 |
| β-Blocker | 1 |
| Oxygen saturation, % | 97 (96–98) |
| FEV1, L/s, mean ± SD (% predicted) | 2.67 ± 0.7 (115.5 ± 19.1) |
| FVC, L, mean ± SD (% predicted) | 3.57 ± 0.8 (123.3 ± 21.9) |
| BMI, kg/m2, mean ± SD | 26.04 ± 3.7 |
| Blood pressure, mm Hg | 142 (132–149) |
| Creatinine, μmol/L | 79 (69.5–80.5) |
| ALT, μmol/L | 17 (15–22) |
| Bilirubin, μmol/L | 8 (7–10) |
| CK, IU/L | 80 (59.5–134.5) |
| TSH, mIU/L | 1.9 (1.1–3.7) |
Definition of abbreviations: ACEi = angiotensin-converting enzyme inhibitor; ALT = alanine aminotransferase; BMI = body mass index; CK = creatine kinase; TSH = thyroid-stimulating hormone.
All values represent median (interquartile range), unless otherwise stated.